Sanofi Launches its First Digital Manufacturing Facility for Delivering Next-Generation Biologics in Massachusetts

 Sanofi Launches its First Digital Manufacturing Facility for Delivering Next-Generation Biologics in Massachusetts

Sanofi Launches its First Digital Manufacturing Facility for Delivering Next Generation Biologics in Massachusetts

Shots:

  • Sanofi inaugurates its first digitally enabled, continuous manufacturing facility in Framingham, Massachusetts, marking one of the world’s first digital facilities utilizing intensified, continuous biologics production technology and will manufacture biologics for the Specialty Care portfolio
  • The focus of the digital manufacturing facility is to leverage better use of data to optimize the company’s manufacturing processes, increasing efficiencies and speeding up the commercialization of new therapies emerging from the R&D pipeline
  • The digital bio-manufacturing facility is a part of Sanofi’s integrated biologics hub in Framingham and utilizes paperless and data-driven manufacturing technologies. Sanofi has successfully completed its process qualification runs in Q3’19

Click here to­ read full press release/ article | Ref: Sanofi | Image: Dalal Street

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post